DUBLIN--(BUSINESS WIRE)-- <\/p>\n
Research and Markets (http:\/\/www.researchandmarkets.com\/research\/5jb3zm\/decision_making<\/a>) has announced the addition of the \"Decision Making in Transfusion Medicine\" book to their offering. <\/p>\n This timely book examines the policy and clinical decisions being made today in the name of blood safety, often resulting in radical changes in transfusion medicine practice. <\/p>\n Although decision making in transfusion medicine is based on a wider range of inputs than solely the best research evidence, the orientation of this book remains evidence-based. In this capacity, the book is intended to serve one of the recurring principles enunciated by the FDA that decision making must be transparent. The book discusses both the evidence supporting and the hotly debated policy alternatives proposed for avoiding the risks of allogeneic blood transfusion. <\/p>\n Topics: <\/p>\n - The contrast between precautionary principle and evidence-based medicine. <\/p>\n - Emerging transmissible infections. <\/p>\n - Pathogen reduction. <\/p>\n - MSM donor deferrals. <\/p>\n - Patient blood management. <\/p>\n <\/p>\n Continued here: <\/p>\n Research and Markets: The Book Decision Making in Transfusion Medicine Features Causes of, and strategies to reduce ...<\/a><\/p>\n","protected":false},"excerpt":{"rendered":" DUBLIN--(BUSINESS WIRE)-- Research and Markets (http:\/\/www.researchandmarkets.com\/research\/5jb3zm\/decision_making<\/a>) has announced the addition of the \"Decision Making in Transfusion Medicine\" book to their offering. Continue reading